Effects of the association of potassium citrate and Agropyrum repens in renal stone treatment: Results of a prospective randomized comparison with potassium citrate

Archivio Italiano di Urologia e Andrologia

Volumn 84, Issue 2, 2012, Pages 61-67

  Brardi, Simone ^a   Imperiali, Patrizio ^a   Cevenini, Gabriele ^b   Verdacchi, Tiziano ^a   Ponchietti, Roberto ^b  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Dry extract of couch grass; Nephrolithiasis; Potassium titrate; Prospective randomized study

Indexed keywords

AGROPYRUM REPENS EXTRACT; ALLOPURINOL; AMILORIDE; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; CALCIUM; CALCOMEV; CITRATE POTASSIUM; CITRIC ACID; HYDROCHLOROTHIAZIDE; OXALIC ACID; PLANT EXTRACT; PROTEIN; PYRIDOXINE; SODIUM; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGROPYRON REPENS; ARTICLE; CALCIUM INTAKE; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUID INTAKE; FOLLOW UP; GRASS; HUMAN; MALE; MEDICINAL PLANT; METABOLIC DISORDER; NEPHROLITHIASIS; PALATIBILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SODIUM INTAKE; TREATMENT DURATION; URIC ACID URINE LEVEL; URINARY EXCRETION; URINE PH;

FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POACEAE; POTASSIUM CITRATE; PROSPECTIVE STUDIES;

EID: 84865198544     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Charles YC Pak. Pharmacotherapy of kidney stones. Expert Opin. Pharmacother 2008; 9:1509-1518.
2. Barcelo P, Wuhl O, Servitge E, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150:1761-1764. (Pubitemid 24350792)
3. Ettinger B, Pak HP, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997; 158:2069-2073. (Pubitemid 27481329)
4. Hofbauer JK, Höbarth, Szabo N, et al. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis: a prospective randomized study. Br J Urol 1994, 73: 362-365.
5. Moe OW, Pearle MS, Sakhaee K. Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney International 2011; 79:385-392.
6. Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital Urol Androl 2009; 81(3):182-7. Review.
7. Soygur T, Akbay A, Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 2002; 16: 149-152. (Pubitemid 34438765)
8. Paslawska S, Piekos R. Studies on the optimum conditions of extraction of silicon species from plants with water. IV. Agropyron repens. Planta Med 1976; 30:216-222.
9. Mascolo N Biological screening of Italian medicinal plants for anti-inflammatory activity. Phytother Res 1987; 1:28-29.
10. Weston LA, et al. Isolation, characterization and activity of phytotoxic compounds from quackgrass (Agropyron repens (L.) Beauv.). J Chem Ecol 1987; 13:403-421.
11. Pratt R, Youngken HW. Pharmacognosy: the study of natural drug substances and certain allied products. Philadelphia: J.B. Lippincott Company, 1951.
12. Anonymous. Community herbal monograph on Agropyron repens (L.) P. Beauv., Rhizoma. EMA/HMPC/563408/2010. Committee on Herbal Medicinal Products (HMPC). European Medicines Agency. An agency of the European Union. © European Medicines Agency, 2011.
13. Anonymous. List of references supporting the assessment of Agropyron repens (L.) P. Beauv., Rhizome. EMA/HMPC/563402/2010. Committee on Herbal Medicinal Products (HMPC). European Medicines Agency. An agency of the European Union. © European Medicines Agency, 2011.
14. Capasso F, Grandolini G, Izzo AA. Fitoterapia: impiego razionale delle droghe vegetali. Aggiornamento della II edizione di Fitofarmacia (F. Capasso, G. Grandolini). Springer Verlag Editore; 2006.
15. Kahn AM. Effect of diuretics on the renal handling of urate. Semin Nephrol. 1988; 8:305.
16. Weinman EJ, Eknoyan G, Suki WN. The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. J Clin Invest. 1975; 55:283.
17. Steele TH, Oppenhiemer S. Factors Affecting urate excretion following diuretic administration in man. Am J Med 1969; 47:564.
18. Carlsen JE, Kober L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990; 300:975.
19. Nijenhuis T, Hoenderop JG, Loffing J, et al. Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2 + transport proteins in kidney. Kidney Int 2003; 64:555.
20. Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2 + reabsorption and reduced Mg2 + channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005; 115:1651.
21. Curhan GC, Goldfarb S, Forman JP. Prevention of recurrent calcium stones in adults. wwwuptodate.com version 19.2. May 2011.